Abstract
As is the case with other drugs of abuse, a proportion of ecstasy users develop symptoms consistent with a substance use disorder (SUD). In this paper, we propose that the pharmacology of MDMA, the primary psychoactive component of ecstasy tablets, changes markedly with repeated exposure and that neuroadaptations in dopamine and serotonin brain systems underlie the shift from MDMA use to MDMA misuse in susceptible subjects. Data from both the human and laboratory animal literature are synthesized to support the idea that (1) MDMA becomes a less efficacious serotonin releaser and a more efficacious dopamine releaser with the development of behaviour consistent with an SUD and (2) that upregulated serotonin receptor mechanisms contribute to the development of the MDMA SUD via dysregulated inhibitory control associated with the trait of impulsivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113(2):296–320
Anastasio NC et al (2011) The serotonin (5-Ht) 5-Ht2a receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats. Behav Pharmacol 22(3):248
Anastasio NC et al (2015) Serotonin (5-HT) 5-HT2A receptor (5-HT2AR): 5-HT2CR imbalance in medial prefrontal cortex associates with motor impulsivity. ACS Chem Neurosci 6(7):1248–1258
Aznar S, Klein AB (2013) Regulating prefrontal cortex activation: an emerging role for the 5-HT(2)A serotonin receptor in the modulation of emotion-based actions? Mol Neurobiol 48(3):841–853
Ball KT et al (2009) Sensitizing regimens of (+/−)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat. Neuroscience 160(2):264–274
Ball KT et al (2010) Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (+/−)3,4-methylenedioxymethamphetamine (ecstasy) in rats: role of drug context. Neuroscience 171(3):794–811
Ball KT et al (2011) Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration. Behav Pharmacol 22(8):847–850
Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26(1):40–52
Baumann MH et al (2008) Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152(3):773–784
Beckwith S, Czachowski CL (2014) Increased delay discounting tracks with a high ethanol-seeking phenotype and subsequent ethanol seeking but not consumption. Alcohol Clin Exp Res 38(10):2607–2614
Belin D et al (2008) High impulsivity predicts the switch to compulsive cocaine-taking. Science 320(5881):1352–1355
Benningfield MM, Cowan RL (2013) Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity. Neuropsychopharmacology 38(1):253–255
Biezonski DK, Meyer JS (2011) The nature of 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonergic dysfunction: evidence for and against the neurodegeneration hypothesis. Curr Neuropharmacol 9(1):84–90
Bird J, Schenk S (2013) Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration. Addict Biol 18(4):654–664
Blokland A (1998) Reaction time responding in rats. Neurosci Biobehav Rev 22(6):847–864
Blokland A, Sik A, Lieben C (2005) Evaluation of DOI, 8-OH-DPAT, eticlopride and amphetamine on impulsive responding in a reaction time task in rats. Behav Pharmacol 16(2):93–100
Bosch OG et al (2013) Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users. PLoS ONE 8(4):e61234
Bradbury S, Gittings D, Schenk S (2012) Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D(1)- and D(2)-like agonists. Psychopharmacology 223(4):389–399
Bradbury S et al (2014) Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release. Addict Biol 19(5):874–884
Brennan KA et al (2009) Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behav Pharmacol 20(8):688–694
Bubar MJ et al (2004) Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. Psychopharmacology 173(3–4):326–336
Cadoni C et al (2005) Effect of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine transmission in the nucleus accumbens shell and core. Brain Res 1055(1–2):143–148
Cahir M et al (2007) Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology 190(4):497–506
Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254(2):456–464
Capela JP et al (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39(3):210–271
Carati C, Schenk S (2011) Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats. Pharmacol Biochem Behav 98(3):449–454
Childress AR et al (1993) Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 137:73–95
Clark L, Cools R, Robbins TW (2004) The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 55(1):41–53
Cole JC, Sumnall HR (2003) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 27(3):199–217
Colussi-Mas J, Schenk S (2008) Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Eur J Neurosci 28(9):1895–1910
Colussi-Mas J et al (2010) Drug-seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. Int J Neuropsychopharmacol 13(10):1315–1327
Cottler LB et al (2001) Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 16(8):599–606
Cottler LB, Leung KS, Abdallah AB (2009) Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Addiction 104(10):1679–1690
Cowan RL (2007) Neuroimaging research in human MDMA users: a review. Psychopharmacology 189(4):539–556
Crombag HS et al (2008) Review. Context-induced relapse to drug-seeking: a review. Philos Trans R Soc Lond B Biol Sci 363(1507):3233–3243
Cunningham KA, Anastasio NC (2014) Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 76:460–478
Curran HV, Travill RA (1997) Mood and cognitive effects of +/−3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week low. Addiction 92(7):821–831
Dalley JW et al (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315(5816):1267–1270
Daniela E et al (2004) Effect of SCH 23390 on (+/−)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77(4):745–750
Daniela E, Gittings D, Schenk S (2006) Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. Behav Neurosci 120(5):1144–1150
Davis AK, Rosenberg H (2014) The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users. J Psychoactive Drugs 46(2):154–161
De Wit H (2009) Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 14(1):22–31
Degenhardt L, Bruno R, Topp L (2010) Is ecstasy a drug of dependence? Drug Alcohol Depend 107(1):1–10
Di Ciano P, Everitt BJ (2004) Conditioned reinforcing properties of stimuli paired with self-administered cocaine, heroin or sucrose: implications for the persistence of addictive behaviour. Neuropharmacology 47(Suppl 1):202–213
Di Giovanni G, Esposito E, Di Matteo V (2010) Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther 16(3):179–194
Di Iorio CR et al (2012) Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry 69(4):399–409
Diergaarde L et al (2008) Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63(3):301–308
Doherty MD, Pickel VM (2000) Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864(2):176–185
Economidou D et al (2009) High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry 65(10):851–856
Esposito E, Di Matteo V, Di Giovanni G (2008) Serotonin-dopamine interaction: an overview. Prog Brain Res 172:3–6
Evenden JL (1999) Varieties of impulsivity. Psychopharmacology 146(4):348–361
Evenden J, Ryan C (1999) The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology 146(4):413–421
Everitt BJ, Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology 153(1):17–30
Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8(11):1481–1489
Everitt BJ, Robbins TW (2013) From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev 37(9):1946–1954
Everitt BJ et al (2008) Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363(1507):3125–3135
Fantegrossi WE et al (2004) Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 29(7):1270–1281
Fink LH et al (2015) Individual differences in impulsive action reflect variation in the cortical serotonin 5-HT2A receptor system. Neuropsychopharmacology
Fletcher PJ, Robinson SR, Slippoy DL (2001) Pre-exposure to (+/−)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology 25(2):195–203
Fletcher PJ et al (2007) Opposing effects of 5-HT2A and 5-HT2C receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 195(2):223–234
Gabbott PL et al (2005) Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 492(2):145–177
Gerra G et al (2003) Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity. Psychiatry Res 120(2):115–124
Gold LH, Hubner CB, Koob GF (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology 99(1):40–47
Grimm JW et al (2001) Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412(6843):141–142
Heal DJ et al (1985) Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 24(12):1201–1205
Homberg JR (2012) Serotonin and decision making processes. Neurosci Biobehav Rev 36(1):218–236
Hoover WB, Vertes RP (2007) Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 212(2):149–179
Hopper JW et al (2006) Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug Alcohol Depend 85(3):221–235
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71(4):533–554
Huxster JK, Pirona A, Morgan MJ (2006) The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 20(2):281–290
Jasinska AJ et al (2014) Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 38:1–16
Johanson CE et al (2006) Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Drug Alcohol Depend 81(1):27–36
Kalivas PW (2008) Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res 14(2–3):185–189
Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10(8):561–572
Kalivas PW, Duffy P, White SR (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18(6):469–479
Kirisci L et al (2007) Developmental trajectory classes in substance use disorder etiology. Psychol Addict Behav 21(3):287
Kirkpatrick MG et al (2012) A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 219(1):109–122
Kirkpatrick MG et al (2014) MDMA effects consistent across laboratories. Psychopharmacology 231(19):3899–3905
Koffarnus MN, Woods JH (2013) Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose. Addict Biol 18(1):8–18
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217–238
Koskinen T, Sirviö J (2001) Studies on the involvement of the dopaminergic system in the 5-HT 2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task. Brain Res Bull 54(1):65–75
Koskinen T, Ruotsalainen S, Sirviö J (2000a) The 5-HT 2 receptor activation enhances impulsive responding without increasing motor activity in rats. Pharmacol Biochem Behav 66(4):729–738
Koskinen T et al (2000b) Activation of 5-HT 2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39(3):471–481
Koskinen T, Haapalinna A, Sirvi J (2003) α-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92(5):214–225
Lichtigfeld FJ, Gillman MA (1998) Antidepressants are not drugs of abuse or dependence. Postgrad Med J 74(875):529–532
Liechti ME, Vollenweider FX (2000) Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10(4):289–295
Liechti ME et al (2000) Psychological and physiological effects of MDMA (“Ecstasy”) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23(4):396–404
Lizarraga LE et al (2014) Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(+/−)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats. Toxicol Sci 139(2):421–431
Loos M et al (2013) Enhanced alcohol self-administration and reinstatement in a highly impulsive, inattentive recombinant inbred mouse strain. Front Behav Neurosci 7
Ludwig V, Mihov Y, Schwarting RK (2008) Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior. Behav Brain Res 189(1):52–64
Marchant NJ et al (2014) Role of corticostriatal circuits in context-induced reinstatement of drug-seeking. Brain Res
McCann UD, Eligulashvili V, Ricaurte GA (2000) (+/−)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42(1):11–16
McCann UD et al (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/−)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance. Psychopharmacology 200(3):439–450
McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J Pharmacol Exp Ther 290(3):965–973
McKetin R et al (2014) The effect of the ecstasy ‘come-down’ on the diagnosis of ecstasy dependence. Drug Alcohol Depend 139:26–32
Mengod G et al (1990) Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524(1):139–143
Modi GM et al (2006) Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. Behav Brain Funct 2:1
Moreno-Sanz G et al (2009) Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement. Int J Neuropsychopharmacol 12(7):929–940
Morgan MJ (1998) Recreational use of “ecstasy”(MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19(4):252–264
Oakly AC et al (2014) A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats. Mol Psychiatry 19(5):534–535
Obradovic T, Imel KM, White SR (1996) Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine. Neuroscience 74(2):469–481
Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol 19(1):71–83
Parrott AC (2013) Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. Hum Psychopharmacol 28(4):289–307
Parrott AC, MDMA is certainly damaging after 25 years of empirical research: A reply and refutation of Doblin et al (2014). Human Psychopharmacology, 2014. 29(2): p. 109–119
Passetti F, Dalley JW, Robbins TW (2003) Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology 165(2):136–145
Pattij T, Vanderschuren LJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29(4):192–199
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346(2):205–230
Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1(4):273–277
Perry JL, Carroll ME (2008) The role of impulsive behavior in drug abuse. Psychopharmacology 200(1):1–26
Perry JL et al (2005) Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology 178(2–3):193–201
Perry JL, Nelson SE, Carroll ME (2008a) Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 16(2):165–177
Perry JL, Nelson SE, Carroll ME (2008b) Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Experiment Clin Psychopharmacol 16(2):165
Poulos CX, Le A, Parker J (1995) Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol
Regier PS et al (2014) Cocaine-, caffeine-, and stress-evoked cocaine reinstatement in high vs. low impulsive rats: treatment with allopregnanolone. Drug Alcohol Depend 143:58–64
Reneman L et al (2002) Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study–preliminary report. Psychopharmacology 159(3):335–340
Reveron ME, Maier EY, Duvauchelle CL (2010) Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine (“Ecstasy”) self-administration. Behav Brain Res 207(2):500–507
Ricaurte GA, Yuan J, McCann UD (2000) (+/−)3,4-methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42(1):5–10
Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248(3):1010–1017
Robbins T (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163(3–4):362–380
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396(2):157–198
Rothman RB, Baumann MH (2006) Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 1074:245–260
Ruotsalainen S et al (1997) Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. Eur Neuropsychopharmacol 7(2):99–108
Schenk S (2011) MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity. Neurosci Biobehav Rev 35(5):1203–1218
Schenk S, Bradbury S (2015) Persistent sensitisation to the locomotor activating effects of MDMA following MDMA self-administration in rats. Pharmacol Biochem Behav 132:103–107
Schenk S, Partridge B (2001) Influence of a conditioned light stimulus on cocaine self-administration in rats. Psychopharmacology 154(4):390–396
Schenk S et al (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169(1):21–27
Schenk S et al (2007) MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci 26(11):3229–3236
Schindler CW, Panlilio LV, Goldberg SR (2002) Second-order schedules of drug self-administration in animals. Psychopharmacology 163(3–4):327–344
Schultz W (1997) Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 7(2):191–197
Shankaran M, Gudelsky GA (1999) A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology 147(1):66–72
Sher KJ, Bartholow BD, Wood MD (2000) Personality and substance use disorders: a prospective study. J Consult Clin Psychol 68(5):818
Shortall SE et al (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 23(9):1085–1095
Smith JL et al (2014) Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. Drug Alcohol Depend 145:1–33
Soar K, Turner JJ, Parrott AC (2006) Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. J Psychopharmacol 20(3):417–424
Tai YF et al (2011) Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA (‘Ecstasy’): an 18F-dopa PET study. Neuropsychopharmacology 36(4):735–743
Talpos JC, Wilkinson LS, Robbins TW (2006) A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharm 20(1):47–58
Tancer ME, Johanson CE (2001) The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend 65(1):97–101
Tancer M, Johanson CE (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72(1):33–44
Tarter RE et al (2007) Modeling the pathways linking childhood hyperactivity and substance use disorder in young adulthood. Psychol Addict Behav 21(2):266
Topp L et al (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55(1–2):105–115
Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613–672
Urban NB et al (2012) Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [(1)(1)C]DASB and [(1)(1)C]MDL 100907. Neuropsychopharmacology 37(6):1465–1473
Volkow ND, Baler RD (2014) Addiction science: uncovering neurobiological complexity. Neuropharmacology 76:235–49
Voorn P et al (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27(8):468–474
Wee S, Woolverton WL (2006) Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84(2):337–343
Wee S et al (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313(2):848–854
Weiss F et al (1992) Neurochemical correlates of cocaine and ethanol self-administration. Ann NY Acad Sci 654:220–241
White SR, Duffy P, Kalivas PW (1994) Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62(1):41–50
Winstanley CA et al (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176(3–4):376–385
Yang PB, Atkins KD, Dafny N (2011) Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats. Eur J Pharmacol 661(1–3):72–85
Yen CF, Hsu SY (2007) Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents. J Nerv Ment Dis 195(10):866–869
Zlebnik NE, Carroll ME (2015) Effects of the combination of wheel running and atomoxetine on cue-and cocaine-primed reinstatement in rats selected for high or low impulsivity. Psychopharmacology 232(6):1049–1059
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Schenk, S., Aronsen, D. (2015). Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA (‘Ecstasy’) Substance Use Disorder. In: Nielsen, S., Bruno, R., Schenk, S. (eds) Non-medical and illicit use of psychoactive drugs. Current Topics in Behavioral Neurosciences, vol 34. Springer, Cham. https://doi.org/10.1007/7854_2015_421
Download citation
DOI: https://doi.org/10.1007/7854_2015_421
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60014-7
Online ISBN: 978-3-319-60016-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)